CapsoVision, Inc. (NASDAQ:CV) Short Interest Update

CapsoVision, Inc. (NASDAQ:CV) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totaling 1,244,098 shares, an increase of 124.8% from the March 15th total of 553,348 shares. Based on an average daily trading volume, of 815,476 shares, the days-to-cover ratio is presently 1.5 days. Currently, 2.5% of the shares of the company are sold short.

Hedge Funds Weigh In On CapsoVision

Large investors have recently modified their holdings of the stock. New York State Common Retirement Fund acquired a new stake in CapsoVision in the third quarter worth about $34,000. Deutsche Bank AG acquired a new stake in shares of CapsoVision during the 4th quarter worth approximately $47,000. Wells Fargo & Company MN lifted its holdings in CapsoVision by 66.4% in the fourth quarter. Wells Fargo & Company MN now owns 6,287 shares of the company’s stock valued at $67,000 after buying an additional 2,508 shares during the period. Citadel Advisors LLC bought a new position in CapsoVision in the third quarter valued at approximately $115,000. Finally, Virtu Financial LLC bought a new stake in shares of CapsoVision during the 4th quarter valued at $128,000.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on CV. Weiss Ratings reissued a “sell (e)” rating on shares of CapsoVision in a research report on Monday, December 29th. Wall Street Zen raised CapsoVision to a “hold” rating in a research report on Saturday, January 10th. Finally, Benchmark cut their price target on shares of CapsoVision from $14.00 to $10.00 and set a “speculative buy” rating for the company in a research note on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

CapsoVision Trading Up 0.8%

CV stock traded up $0.05 during trading on Monday, hitting $6.30. 44,961 shares of the stock traded hands, compared to its average volume of 403,394. The stock has a market cap of $313.89 million and a price-to-earnings ratio of -2.87. CapsoVision has a one year low of $3.43 and a one year high of $15.37. The company has a 50 day simple moving average of $5.78 and a 200 day simple moving average of $6.45.

CapsoVision (NASDAQ:CV) last posted its quarterly earnings data on Thursday, March 26th. The company reported $0.02 earnings per share for the quarter. The firm had revenue of $3.92 million for the quarter.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.